A Phase II Study of High-Dose Cetuximab plus Irinotecan in Colorectal Cancer Patients with KRAS Wild-Type Tumors Who Progressed after Standard Dose of Cetuximab plus Irinotecan

Oncology 2013;84:210–213 (DOI:10.1159/000346328)
Source: Karger Publishers - Category: Cancer & Oncology Source Type: research